Krypton red laser photocoagulation for subretinal neovascularization.
One hundred fifty-seven patients with subretinal neovascularization (SRN) were treated in a prospective, nonrandomized, consecutive study with the krypton red laser (KRL). The patients were analyzed with respect to age, etiology of the SRN, location of the SRN, and pre- and post-treatment visual acuity in patients with at least three months follow-up. Previous studies have not investigated KRL photocoagulation within the foveal avascular zone (FAZ). The results of this study compare favorably with other large series in which patients with SRN located outside the FAZ were treated with the argon blue-green laser (ABGL).
J L
JL
Shakin
L A
LA
Yannuzzi
E P
EP
Shakin
Y L
YL
Fisher
D000328:Adult; D000368:Aged; D005500:Follow-Up Studies; D006801:Humans; D053685:Laser Therapy; D007834:Lasers / Q000009:adverse effects; D008028:Light Coagulation / Q000009:adverse effects; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000503:physiopathology / Q000601:surgery*; D011183:Postoperative Complications; D011446:Prospective Studies; D012008:Recurrence; D012171:Retinal Vessels / Q000528:radiation effects*; D014792:Visual Acuity